Publication: 2103

Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy
      QxMD      Google Scholar   
Citation:
J Clin Oncol vol 32 (10) 1066-1073
Year:
2014
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
3
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Lymphoma
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821 , P30 CA015083, P30 CA086862, P50 CA097274, P50 CA97274  
Corr. Author:
 
Authors:
                                               
Networks:
 
Study
NCCTG-N0489
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
Bios3, Bios4, Hema10, ORIGINAL REPORTS, Hematologic Malignancy